Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FdgJz-lWVYiiMk3zrRVR-mXaeMs0.uncropped.jpg&w=3840&q=75)
Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedDifference0.3%
- CheckyesterdayChange DetectedDifference0.9%
- Check2 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version v2.10.0, adding 3 more conditions and noting that the study now includes 18 locations, while the previous version v2.9.7 has been removed.SummaryDifference0.9%
- Check5 days agoChange DetectedDifference0.4%
- Check7 days agoChange DetectedDifference0.4%
- Check8 days agoChange DetectedDifference0.9%
Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.